LACSMI is a preclinical contract research organization (CRO) that provides services in drug discovery and development for Pharmaceutical, Biotech, Agrochemicals, Nutraceutical, Cosmetic and Medical Device industries.
LACSMI offers full services in the areas of preclinical toxicology testing, in vivo and in vitro testing, ADME, and pharmacodynamic testing, and as per ICH guidelines for Investigational New Drug (IND) application. The company also offers testing of carcinogens for biological/pharmaceutical derived molecules for New Drug Application (NDA). In addition, the company also provides services for antibody production, in vivo and in vitro model development and preclinical testing. LACSMI follows strict standards of research by complying with the OECD guidelines
LACSMI has 8,000-square-foot built up area, environmentally controlled animal facilities, surgery suites, clinical pathology labs, necropsy labs, archives and surgery lab.
In addition, the company also has scope for additional 40,000 square-foot free land for future expansion in the same premises.
We are registered under CPCSEA. with Registration Number: 1277/PO/RcBt/S09/CPCSEA